(Q42923655)

English

Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization

scientific article published on June 1, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization (English)

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

pharmacotherapy

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

hospital readmission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800800

3 July 2024

5

object named as

Alain Weill

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800800

3 July 2024

author name string

Philippe Tuppin

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Anke Neumann

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Nicolas Danchin

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Christine de Peretti

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Philippe Ricordeau

6

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Hubert Allemand

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20800800

3 July 2024

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1875213610001142?httpAccept=text/xml

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

https://api.elsevier.com/content/article/PII:S1875213610001142?httpAccept=text/plain

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Archives of Cardiovascular Diseases

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

6-7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

363-375

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Trends in coronary heart disease in France during the second half of the 1990s

1

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

2

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome

3

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective

4

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP)

5

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.

6

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative

7

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)

8

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study

9

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Long term survival after evidence based treatment of acute myocardial infarction and revascularisation: follow-up of population based Perth MONICA cohort, 1984-2005

10

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

11

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Use of statins and beta-blockers after acute myocardial infarction according to income and education

12

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up

13

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes

14

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease

15

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Continuation of statin treatment and all-cause mortality: a population-based cohort study

16

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

17

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

18

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease

19

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Impact of medication therapy discontinuation on mortality after myocardial infarction

20

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients

21

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction

22

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?

23

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Characteristics and management of diabetic patients hospitalized for myocardial infarction in France.

24

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction

25

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey

27

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

28

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Withdrawal of statins increases event rates in patients with acute coronary syndromes

29

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era

30

1 reference

10.1016/J.ACVD.2010.05.003

https://api.crossref.org/works/10.1016/J.ACVD.2010.05.003

3 July 2024

Identifiers

10.1016/J.ACVD.2010.05.003

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42923655&oldid=2194308226"